Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx
Proposed acquisition will add new anatomic pathology services, proprietary PCR tests and a national client base Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), a technology-based company...